Clinical Trial Detail

NCT ID NCT02978547
Title The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma (Metformin 001)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

pancreatic ductal adenocarcinoma

Therapies

Metformin

Age Groups: adult senior

No variant requirements are available.